Search
for
Sort by
Research 601–630 of 1000+
- Highly efficient nucleophilic addition of alkyl Grignard reagents to 17-ketosteroids in the presence of cerium(III) chloride: Synthesis of 17α-propyl-17β-hydroxy-4-androsten-3-one, an androgen receptor antagonist
- ANTIANDROGENS AND THE SKIN
- Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency
- Association of Spironolactone Use With Risk of Cancer
- PCPT, MTOPS and the use of 5ARIs: a Canadian consensus regarding implications for clinical practice
- Synthesis and Pharmacological Evaluation of New Progesterone Esters as 5.ALPHA.-Reductase Inhibitors
- Dutasteride‐mediated morphological changes in the genitourinary tract associated with altered expression patterns of the androgen and estrogen receptors in male rats
- Comparison Between Two Different Hamster Models used for the Determination of Testosterone and Finasteride Activity
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- The natural history of androgenetic alopecia
- Dutasteride, a novel dual 5-A reductase inhibitor, reduces serum DHT to a greater extent versus finasteride and achieves finasteride maximal reduction in a larger proportion of patients
- Synthesis and in Vitro Evaluation of 4-Substituted N-(1,1-Dimethylethyl)-3-oxo-4-androstene-17.beta.-carboxamides as 5.alpha.-Reductase Inhibitors and Antiandrogens
- 25 years of ERβ: a personal journey
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Economic Issues in the Treatment of BPH
- The Use of Stromal Vascular Fraction in the Treatment of Male Sexual Dysfunction: A Review of Preclinical and Clinical Studies
- Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: a serious concern or red herring?
- Cancer risk by the subtype of alopecia
- Preventive and Therapeutic Efficacy of Finasteride and Dutasteride in TRAMP Mice
- COMBINATION OF AN ANTIANDROGEN AND A 5α-REDUCTASE INHIBITOR: A FURTHER STEP TOWARDS TOTAL ANDROGEN BLOCKADE?
- Telocytes of the male reproductive system: dynamic tissue organizers
- Efectos adversos de finasteride: mitos y realidades. Una revisión actualizada
- Effects of <i>In Utero</i> Exposure to D-004, a Lipid Extract from <i>Roystonea regia</i> Fruits, in the Male Rat: A Comparison with Finasteride
- Influence of Dosing Time on the Efficacy and Safety of Finasteride in Rats
- Omega-6 highly unsaturated fatty acids in Leydig cells facilitate male sex hormone production
- Synthesis, biological evaluation and molecular docking of 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs containing the piperazine moiety
- Male pattern baldness and risk of colorectal neoplasia
- Dutasteride vs finasteride: assessment of differences in acute urinary retention rates and surgical risk outcomes in an elderly population aged > or =65 years.
- The five-year effects of testosterone replacement therapy on lipid profile and glucose tolerance among hypogonadal men in Japan: a case control study
- Relation of urinary stone disease with androgenetic alopecia and serum testosterone levels